美国药品NDC(国家药品编码)与药品说明书数据库(U.S. FDA National Drug Code DataBase)
检索条件:" 注册申请号=ANDA207124"
NDC包装代码 产品NDC 产品类型 商品名 通用名 剂型 给药途径 上市日期 结束日期 市场类别 申请号 标签持有者 活性成分 规格 包装描述
0480-7013-56 0480-7013 HUMAN PRESCRIPTION DRUG Deferasirox Deferasirox TABLET, FOR SUSPENSION ORAL 20241101 N/A ANDA ANDA207124 Teva Pharmaceuticals, Inc. DEFERASIROX 500 mg/1 30 TABLET, FOR SUSPENSION in 1 BOTTLE (0480-7013-56)
0480-7011-56 0480-7011 HUMAN PRESCRIPTION DRUG Deferasirox Deferasirox TABLET, FOR SUSPENSION ORAL 20241101 N/A ANDA ANDA207124 Teva Pharmaceuticals, Inc. DEFERASIROX 125 mg/1 30 TABLET, FOR SUSPENSION in 1 BOTTLE (0480-7011-56)
0480-7012-56 0480-7012 HUMAN PRESCRIPTION DRUG Deferasirox Deferasirox TABLET, FOR SUSPENSION ORAL 20241101 N/A ANDA ANDA207124 Teva Pharmaceuticals, Inc. DEFERASIROX 250 mg/1 30 TABLET, FOR SUSPENSION in 1 BOTTLE (0480-7012-56)
商品名称,通用名称,活性成分名称,申请号搜索 高级检索
©2006-2025 Drugfuture->U.S. FDA National Drug Code DataBase